共 50 条
- [2] Mirodenafil: a new PDE5 inhibitor for the treatment of erectile dysfunction [J]. Nature Clinical Practice Urology, 2009, 6 (2): : 60 - 60
- [3] WHAT IS THE OVERALL SAFETY AND EFFICACY OF INHIBITORS OF THE PHOSPHODIESTERASE TYPE 5 ENZYME (PDE5) IN THE TREATMENT OF ERECTILE DYSFUNCTION? [J]. JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 89 - 89
- [4] Phosphodiesterase Type 5 (PDE5) Inhibitors in Erectile Dysfunction: The Proper Drug for the Proper Patient [J]. JOURNAL OF SEXUAL MEDICINE, 2011, 8 (12): : 3418 - 3432
- [6] Patterns of PDE5 inhibitor use in patients with erectile dysfunction [J]. Nature Clinical Practice Urology, 2006, 3 (1): : 6 - 6
- [7] PDE5 Inhibitors for Erectile Dysfunction [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2012, 54 (1383): : 10 - 11
- [8] Erectile dysfunction : Treatment with inhibitor drugs of type 5 phosphodiesterase [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2007, 53 (02): : 102 - 103
- [9] COMPREHENSIVE TREATMENT OF MALE PSYCHOGENIC ERECTILE DYSFUNCTION BY SEX THERAPY ADN PSYCHOTROPIC DRUGS (WITHOUT PDE5 INH.) [J]. JOURNAL OF SEXUAL MEDICINE, 2017, 14 (05): : E338 - E338
- [10] PDE5 INHIBITOR TREATMENT PERSISTENCE AND ADHERENCE IN LATIN AMERICAN MEN WITH ERECTILE DYSFUNCTION [J]. JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 314 - 314